Vulante tablets are used for the treatment of human immunodeficiency virus (HIV-1) infection in adults aged 18 years and older. The medication combines antiretroviral drugs including dolutegravir, lamivudine, and tenofovir disoproxil fumarate to manage and suppress HIV infection. It aids in reducing the viral load in the body, helping the immune system work better and reducing the risk of HIV complications. Vulante therapy should be initiated by a medical professional experienced in managing HIV infection.

Vulante tablets are not a cure for HIV but are part of antiretroviral therapy (ART) to control the infection. They are taken orally, usually once daily, with or without food, and it is important to take them exactly as prescribed to prevent resistance and maintain effectiveness.

In summary, Vulante tablets are prescribed for adults with HIV-1 to manage the infection and improve quality of life by controlling the virus.